Cellulitis Treatment Guidelines

Introduction to Cellulitis Treatment

The Infectious Diseases Society of America (IDSA) recommends a 5-day course of antibiotics for uncomplicated cellulitis, with extension if the infection has not improved within this time period, based on high-quality evidence 1, 2

A 5-day course of antibiotics is recommended for cellulitis, with evaluation at day 5 to determine if extended treatment is needed, as supported by the IDSA guidelines with high-quality evidence 1, 2
Certain clinical factors, such as lack of clinical improvement, severe disease, immunocompromised status, extremes of age, and infection in difficult-to-treat areas, may necessitate extending treatment beyond 5 days, according to the guidelines 2, 3
Complete the full course of antibiotics even if symptoms improve quickly, to prevent treatment failure, as recommended by the IDSA with a high strength of evidence 1
Evaluation at day 5 is crucial to determine if extended treatment is needed, with improvement criteria including decreased erythema, warmth, tenderness, and swelling 1

Elevation of the affected area is an important adjunctive measure alongside antibiotic therapy, as recommended by the IDSA with a moderate strength of evidence 1, 2
Examining interdigital spaces for fissuring or maceration that may harbor pathogens is recommended for lower extremity cellulitis, as suggested by the IDSA with a moderate strength of evidence 2, 1
Addressing predisposing factors, such as underlying conditions (e.g. edema, obesity, or skin disorders), is recommended to improve outcomes, as suggested by the IDSA with a moderate strength of evidence 2, 1
For purulent cellulitis, incision and drainage is the primary treatment, with antibiotics as adjunctive therapy, as recommended by the IDSA with a high strength of evidence 3

Hospitalization is recommended for patients with SIRS, altered mental status, hemodynamic instability, concern for deeper or necrotizing infection, poor adherence to therapy, severe immunocompromise, or failure of outpatient treatment, as per the IDSA guidelines 1
For severe infections or immunocompromised patients, the IDSA considers longer initial course or hospitalization, with a moderate strength of evidence 1

Missing underlying conditions, such as untreated predisposing factors, can increase the risk of recurrence, as noted by the IDSA 1
For recurrent infections, the IDSA suggests considering decolonization regimen with intranasal mupirocin and chlorhexidine washes, with a low strength of evidence 1
The National Institute for Health and Care Excellence (NICE) and American College of Physicians (ACP) also recommend a course of antibiotics for cellulitis, with NICE recommending 5-7 days and ACP suggesting 5-6 days 2, 4